Lumida
/ATROB
⌘K
ATROB

ATROB

ATROB
$74.01USD-4.11%-3.17 today

MARKET CAP

3.2B

P/E (TTM)

FWD P/E

DAY RANGE

$72 – $78

52W RANGE

$27
$94

AI Summary

Stalk
TrimMedium

ATROB remains in a Stage 4 decline with medium-term bearish asymmetry. The asset is trading below the 9 EMA, 21 EMA, and 50 DMA, with failed rally attempts indicating persistent selling pressure. Although a Bearish Exhaustion pattern suggests potential stabilization, overall momentum and Stage 4 context favor continued downtrend. Execution should be deferred to rallies into short-term EMA resistance zones for trimming positions.

  • Mission-Ready Edge AI launch cements Astronics’ AI-avionics leadership
  • Zacks upgrade to Rank #2 (Buy) reflects upward earnings revisions
  • Negative earnings yield (–2.7%) highlights profitability challenges
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Astronics Corporation (NASDAQ:ATRO) is a key player in the aerospace and defense sectors, specializing in innovative technology solutions such as avionics, lighting, and power systems. The company focuses on providing advanced products that integrate cutting-edge technologies, including artificial intelligence, to meet the rigorous demands of the rugged environments in which they operate. As a dominant force in avionics and related industries, Astronics is well-positioned to benefit from the ongoing advancements in AI, particularly with its latest offerings aimed at enhancing mission readiness for defense and aerospace applications.

Bull says

  • Mission-Ready Edge AI launch cements Astronics’ AI-avionics leadership
  • Zacks upgrade to Rank #2 (Buy) reflects upward earnings revisions
  • Positive momentum trend indicates growing investor interest
  • 0.75% dividend yield appeals to income-focused investors
  • 70% positive factor exposure underscores strong quality metrics
  • Rising defense budgets and AI demand support future revenue growth

Bear says

  • Negative earnings yield (–2.7%) highlights profitability challenges
  • Profitability metrics remain weak, limiting return generation
  • Leverage risk elevated amid potential interest rate hikes
  • Analysts’ downward earnings revisions signal softening outlook
  • Low book-to-price ratio (0.27) suggests stretched valuation
  • AI hype may disappoint if adoption lags expectations